Letter to the U.S. House of Representatives Opposing the Newest “False Hope” Legislation

March 12, 2018

View as PDF.

In a letter to the U.S. House of Representatives, Public Citizen strongly opposed the “Right to Try Act of 2018.” Although the bill has several improvements over the Senate-passed version of this legislation (S. 204), it still has fundamental flaws that make it dangerous for patients. In particular, the bill would offer false hope to patients by creating a dangerous pathway for access to experimental drugs and biological products that bypasses the Food and Drug Administration’s existing Expanded Access program.

See Public Citizen’s other work on the “False Hope” legislation.